https://www.openbell.ai/ 2026-11-01T20:42:17.567Z hourly 1.0 https://www.openbell.ai/support 2026-11-01T20:42:17.567Z monthly 0.7 https://www.openbell.ai/privacy 2026-11-01T20:42:17.567Z monthly 0.5 https://www.openbell.ai/terms 2026-11-01T20:42:17.567Z monthly 0.5 https://www.openbell.ai/feed.json 2026-11-01T20:42:17.567Z hourly 0.8 https://www.openbell.ai/news/HBM:1793563314000 2026-11-01T20:01:54.000Z daily 0.9 https://cdn.brandfetch.io/HBM/w/400/h/400?c=1idopYfmtR7ZKg8QMud HORNBACH Baumarkt AG Reports 6M 2026/27 Financial Results HORNBACH Baumarkt AG reported first-half 2026/27 sales of €3,816.2 million, up 6.0% year over year, and adjusted EBIT of €285.6 million, up 4.9%. Free cash flow was €194.9 million. The company cited expansion plans, e-commerce growth and stronger cash flow, and maintained its outlook for sales at or slightly above the prior-year level and adjusted EBIT at the prior-year level. https://www.openbell.ai/news/PERI:1793559704000 2026-11-01T19:01:44.000Z daily 0.9 https://cdn.brandfetch.io/PERI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Perion Network Enters into Definitive Merger Agreement with Affle Perion Network agreed to be acquired by Affle 3iL for $11.70 per share in cash, valuing the company at approximately $420 million. The offer represents a 34.5% premium to Perion’s October 30, 2026 closing share price, and was unanimously approved by Perion’s board. A 40-day go-shop period allows Perion to seek alternative proposals; the deal is expected to close in early 2027, subject to regulatory and shareholder approvals. Upon completion, Perion shares will be delisted from Nasdaq and the Tel Aviv Stock Exchange. https://www.openbell.ai/news/KESKOB:1793559699000 2026-11-01T19:01:39.000Z daily 0.9 https://cdn.brandfetch.io/KESKOB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kesko Raises Financial Guidance Following Q3 Profit Growth Kesko raised its financial guidance after reporting profit growth in the third quarter. The article does not provide specific financial figures or details about the revised outlook. https://www.openbell.ai/news/MARUTI:1793547119000 2026-11-01T15:31:59.000Z daily 0.9 https://cdn.brandfetch.io/MARUTI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Maruti Suzuki Reports Record October Sales with 25% Growth Maruti Suzuki India reported record October 2026 sales, up 25% year over year, citing strong festive-season demand for its vehicle portfolio. The report did not provide sales totals, financial results, or stock-price movements. https://www.openbell.ai/news/BTAI:1793541837000 2026-11-01T14:03:57.000Z daily 0.9 https://cdn.brandfetch.io/BTAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud BioXcel Therapeutics Announces Executive Changes and Wind-Down Process BioXcel Therapeutics announced on October 30, 2026, that it terminated four officers and appointed Samir Saleem as president and secretary. The leadership changes come amid a court-supervised bankruptcy sale and the planned wind-down of the company’s affairs. Its stock is trading under the ticker BTAIQ. https://www.openbell.ai/news/NERD:1793541836000 2026-11-01T14:03:56.000Z daily 0.9 https://cdn.brandfetch.io/NERD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nerds On Site Reports Q1 Fiscal 2027 Financial Results Nerds On Site reported a 76% improvement in operating results and a 63% reduction in shareholder loss in the first quarter of fiscal 2027 compared with the prior period. Canadian recurring revenue grew nearly 8%, while operating expenses fell 12%. The company said it is focused on improving operating cash generation and liquidity and expanding opportunities in managed services, cybersecurity, AI products, and U.S. technical services, including AI-enhanced internal and client-facing capabilities. https://www.openbell.ai/news/MBIO:1793541832000 2026-11-01T14:03:52.000Z daily 0.9 https://cdn.brandfetch.io/MBIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Mustang Bio Announces FDA Acceptance of IND Application for MB-109 Mustang Bio announced that the FDA accepted its Investigational New Drug application for MB-109, a novel combination of the company’s MB-101 and MB-108 assets. The candidate is intended to treat recurrent glioblastoma and high-grade astrocytoma. The announcement was reported on October 30, 2026. https://www.openbell.ai/news/USCM:1793541824000 2026-11-01T14:03:44.000Z daily 0.9 https://cdn.brandfetch.io/USCM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Critical Metals Corp. Receives Supreme Court Approval for European Lithium Acquisition Critical Metals Corp. (Nasdaq: CRML) received Supreme Court of Western Australia approval for its proposed acquisition of 100% of European Lithium’s issued share capital and all listed options through a scheme of arrangement. The deal consideration will be paid in newly issued Critical Metals shares. The approval follows favorable votes by European Lithium shareholders and option holders on October 22, 2026, allowing the share issuance to proceed. https://www.openbell.ai/news/SRTS:1793541783000 2026-11-01T14:03:03.000Z daily 0.9 https://cdn.brandfetch.io/SRTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sensus Healthcare Reports Q2 2026 Financial Results and Analyst Rating Update Sensus Healthcare reported a significant revenue decline and an adjusted net loss in Q2 2026. Unit sales fell to 11 after eight funded units were delayed; the units have since been approved and are expected to be recognized in Q3. Lake Street maintained its Buy rating on SRTS but lowered its price target from $4.50 to $4.00. https://www.openbell.ai/news/JRSH:1793541778000 2026-11-01T14:02:58.000Z daily 0.9 https://cdn.brandfetch.io/JRSH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jerash Holdings Reports Quarterly Financial Results and Receives Analyst Price Target Increase Jerash Holdings reported quarterly revenue of $50.2 million, up 27% year over year, and net income of $1.7 million, with a gross margin of 16%. Management attributed the results to improved manufacturing efficiency and higher shipment volumes to the United States. DA Davidson maintained its buy rating and raised its price target from $5.00 to $6.00 per share. https://www.openbell.ai/news/EMBC:1793541750000 2026-11-01T14:02:30.000Z daily 0.9 https://cdn.brandfetch.io/EMBC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Embecta Reports Fiscal Third-Quarter 2026 Financial Results and Updates Guidance Embecta reported fiscal third-quarter 2026 revenue of approximately $272 million, down 8.1% year over year. It reaffirmed full-year revenue guidance of $1.015 billion to $1.035 billion, while raising adjusted EPS guidance to $1.80–$1.90 and adjusted operating margin guidance to 23.5%–24%, citing the earlier-than-expected close of its Owen Mumford acquisition. The company also highlighted its Adaptis auto-injector, generated $41 million in free cash flow, and repaid $53 million of debt. https://www.openbell.ai/news/GO:1793541737000 2026-11-01T14:02:17.000Z daily 0.9 https://cdn.brandfetch.io/GO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Grocery Outlet Shares Surge Following Strong Earnings and Analyst Upgrade Grocery Outlet Holding Corp. shares surged 38.8% on October 31, 2026, their largest single-day gain on record. The rise followed the company’s optimistic earnings-per-share and profit forecasts, alongside a Morgan Stanley upgrade of its stock rating. https://www.openbell.ai/news/IRMD:1793541733000 2026-11-01T14:02:13.000Z daily 0.9 https://cdn.brandfetch.io/IRMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud iRadimed Reduces Full-Year Guidance Amid Production Constraints iRadimed Corporation lowered its full-year guidance because quality-related constraints slowed its production ramp-up. Demand for its four-channel 3870 infusion pump remains strong, supporting bookings and backlog as existing and new customers replace legacy devices. The article did not provide specific financial figures or report a stock-price movement. https://www.openbell.ai/news/XPEV:1793538116000 2026-11-01T13:01:56.000Z daily 0.9 https://cdn.brandfetch.io/XPEV/w/400/h/400?c=1idopYfmtR7ZKg8QMud XPeng Announces Record Vehicle Deliveries for October 2026 XPeng delivered a record 50,237 vehicles in October 2026, up 22% month over month and 20% year over year. Overseas deliveries reached a record 13,326 units, a 166% increase from a year earlier. The company launched the XPeng L05 in mainland China, with customer deliveries set to begin November 1, and secured a Level 4 Robotaxi demonstration-operation license in Guangzhou on October 26, advancing its Physical AI commercialization efforts. https://www.openbell.ai/news/SAFE:1793520222000 2026-11-01T08:03:42.000Z daily 0.9 https://cdn.brandfetch.io/SAFE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Safe at Sea Reports Revenue Decline and Negative Results for Jan–Sep 2026 Safe at Sea AB reported a 33% year-over-year revenue decline for January–September 2026 and negative financial results. The third quarter was particularly weak, as delayed tenders and few product deliveries weighed on performance. Management expects improvement in the fourth quarter of 2026 and first quarter of 2027, citing late-stage sales opportunities and expanded commercial efforts. https://www.openbell.ai/news/RMT:1793520218000 2026-11-01T08:03:38.000Z daily 0.9 https://cdn.brandfetch.io/RMT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Riba Mundo Tecnología Faces Governance and Legal Challenges Riba Mundo Tecnología faces operational constraints after authorities investigating alleged tax irregularities restricted its bank accounts and assets. Banca Profilo has ended its roles as Euronext Growth Advisor, corporate broker and specialist operator with immediate effect, while the company’s auditor has resigned and independent director Maurizio Bernardo plans to step down. CEO Marco Dezi has limited capacity to act, and the company is assessing how its corporate bodies can continue operating. The article reports no financial figures or share-price movement. https://www.openbell.ai/news/ALEUP:1793520212000 2026-11-01T08:03:32.000Z daily 0.9 https://cdn.brandfetch.io/ALEUP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Europlasma Reports Financial Difficulties and Going-Concern Risk Europlasma SA reported gross debt of €26.8 million as of June 30, 2026, up €6.5 million, while net debt rose to €25.8 million from €12.8 million a year earlier. Its debt consists mainly of convertible bond financing, lease liabilities and repayable advances linked to subsidiaries Les Forges de Tarbes and Valdunes Industries. The company said liquidity pressures threaten the short-term continuity of its operations. https://www.openbell.ai/news/BEYOND:1793520209000 2026-11-01T08:03:29.000Z daily 0.9 https://cdn.brandfetch.io/BEYOND/w/400/h/400?c=1idopYfmtR7ZKg8QMud Beyond Frames Agrees to Acquire Corvenia in Reverse Takeover Beyond Frames Entertainment AB signed a definitive agreement to acquire Corvenia through a reverse takeover valued at SEK 239 million. The deal follows earlier commercial collaborations, including a pilot that developed into a commercial agreement, and will integrate Corvenia’s operations into Beyond Frames. The article reports no financial performance figures or stock-price impact. https://www.openbell.ai/news/VH:1793520207000 2026-11-01T08:03:27.000Z daily 0.9 https://cdn.brandfetch.io/VH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Västra Hamnen Corporate Finance Reports Q3 2026 Financial Results Västra Hamnen Corporate Finance reported Q3 2026 revenue of SEK 3.7 million, up 34% year over year, and operating profit of SEK 0.6 million, returning to quarterly profitability. For the first nine months of 2026, revenue totaled SEK 11.8 million and operating profit was SEK 0.8 million. Management credited cost-cutting measures and increased transaction activity, and said smaller IPOs may be more likely in 2027. https://www.openbell.ai/news/ALLPL:1793520205000 2026-11-01T08:03:25.000Z daily 0.9 https://cdn.brandfetch.io/ALLPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lepermislibre Reports H1 2026 Financial Results and Strategic Updates Lepermislibre reported first-half 2026 revenue of €3.78 million, down 20% year over year, mainly due to fewer CPF-funded orders after February regulatory changes. Its operating loss narrowed to €0.35 million, supported by improved gross margins and restructuring savings. The company plans to open ten agencies within six months, with seven operating as of October 2026, and is targeting positive EBITDA in the first half of 2027. An October banking-protocol amendment deferred loan repayments until March 31, 2027. https://www.openbell.ai/news/TOURN:1793520200000 2026-11-01T08:03:20.000Z daily 0.9 https://cdn.brandfetch.io/TOURN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tourn International AB Reports Q3 2026 Interim Results Tourn International AB reported lower revenue in Q3 2026, as declining NAGATO volumes outweighed 189% growth in its AGENCY business unit. EBITDA improved due to cost-reduction measures, and operating cash flow was positive for the first nine months of the year. Management said the company is unlikely to fully meet its 2026 profitable-growth target, but expects Q4 to contribute positively to annual performance.